Summary Total body bone mineral content and bone mineral content in various body sites were measured by dual-photon absorptiometry in 103 patients with non-insulin-dependent diabetes mellitus (NIDDM) and the findings were compared with those for 214 non-diabetic control subjects matched for age and body weight. Neither total body bone mineral content (TBBM) nor the bone mineral density of the third lumbar vertebra (L3 BMD) in the diabetic subjects differed from the values in control subjects of either sex, but the values were significantly decreased in patients diseased for at least five years when compared with control subjects. Regional bone mineral measurement showed prominent bone loss in the truncal site, but no reduction in bone mass was found in the head, pelvis, arms, or legs in either male or female patients. These results suggest that reduced TBBM and L3 BMD are associated with duration of the disease and that a site specific bone defect is present in NIDDM.
Albright and Reifenstein first reported the coexistence of osteopenia and diabetes mellitus in 1948 (1) . Although bone mass has fairly consistently been demonstrated to be decreased in patients with insulin-dependent diabetes mellitus (IDDM) (2) (3) (4) (5) (6) , the relationship between bone mass and non-insulin-dependent diabetes mellitus (NIDDM) is still controversial. Heath and coworkers failed to find an increased incidence of fracture in about 1000 diabetic subjects as compared with anon-diabetic population (7) . However, bone mass has been variously reported to be normal (8) , increased (9) , or decreased (2, 10) in patients with NIDDM.
In order to address this issue further, we measured total body bone mineral content (BMC) and bone mineral content in various body sites in NIDDM patients, using dual photon absorptiometry (DPA). 
DISCUSSION
Levin et al. reported that single photon absorptiometry (SPA) showed a bone loss greater than 10% in 60% of NIDDM patients examined (2). Ishida et al., who utilized microdensimetry (MD), also reported that bone mass was significantly decreased in about 40% of diabetic patients examined (10) . On the other hand, Johnson et al. found that the bone mass determined by SPA was greater in postmenopausal diabetic women than in control postmenopausal subjects (9) . It should be pointed out, however, that SPA and MD were carried out at the forearm or metacarpus, where cortical bone was dominant. Since cortical bone mass is known to be a less accurate index of the osteoporotic state than trabecular bone mass (14) , changes in cortical bone mass may not always parallel those in the mass of trabecular bone such as the lumbar spine and might not necessarily reflect what is occurring in the entire body bone (15) . The present study showed that the BMD of L3, which is rich in trabecular bone, in NIDDM patients was similar to that in healthy subjects. This finding was consistent with Weinstock's observation (8) 
